When weighing the drawbacks and dangers of semaglutide, you and your healthcare provider should consider whether: You have a personal or family medical history that prevents you from taking semaglutide The drug is FDA-approved or a compounded version The drugs cost and supply chain issues will limit your access The drug is needed to treat diabetes, promote weight loss or do a combination of the two The medication is prescribed for an on- or off-label use, or both You may be eligible to take legal action against Novo Nordisk if you have wrongfully suffered after using semaglutide
Clinical studies, such as the STEP trials, have shown that adults using semaglutide GLP-1 at the recommended dose (2.4 mg weekly) can lose an average of about 15% of their initial body weight over 68 weeks when combined with healthy lifestyle changes
The FDAs decision to ban compounded medications is a regulatory action aimed at addressing safety concerns associated with drugs that are made by compounding pharmacies
Never leave it on a windowsill, a sunlit counter, or anywhere with direct light exposure, even briefly
Rare but Serious Side Effects Pancreatitis presents as severe, persistent abdominal pain that may radiate to the back, accompanied by nausea and vomiting
